Market Indices
Sector Heatmap
PHAT — Phathom Pharmaceuticals, Inc. Common Stock
NasdaqPhathom Pharmaceuticals, Inc. Common Stock
- O
- 6.87
- H
- 7.03
- L
- 6.60
- V
- 1.63M
PHAT — Latest News & Headlines
13 StoriesPHAT Stock Clocks Worst Day In Over 1.5 Years — What Sparked The Selloff? - Stocktwits
PHAT Stock Clocks Worst Day In Over 1.5 Years — What Sparked The Selloff? Stocktwits
Heartburn medicine taken only when symptoms strike is being tested in a new study. - Stock Titan
Heartburn medicine taken only when symptoms strike is being tested in a new study. Stock Titan
PHAT Oct 2026 7.500 put (PHAT261016P00007500) stock price, news, quote and history - Yahoo Finance UK
PHAT Oct 2026 7.500 put (PHAT261016P00007500) stock price, news, quote and history Yahoo Finance UK
Liquidity Mapping Around (PHAT) Price Events - Stock Traders Daily
Liquidity Mapping Around (PHAT) Price Events Stock Traders Daily
PHAT Oct 2026 10.000 call (PHAT261016C00010000) interactive stock chart - Yahoo Finance Australia
PHAT Oct 2026 10.000 call (PHAT261016C00010000) interactive stock chart Yahoo Finance Australia
Hoa Phat stock gets a 34 percent Q3 profit forecast - AD HOC NEWS
Hoa Phat stock gets a 34 percent Q3 profit forecast AD HOC NEWS
PHAT Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares Modestly - EPS Guidance Update - https://www.siam.in/
PHAT Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares Modestly - EPS Guidance Update https://www.siam.in/
AMZN Stock Soars 7% After-Hours — Amazon’s Q2’26 AWS Sales Grow At Fastest Pace In Five Years - Stocktwits
AMZN Stock Soars 7% After-Hours — Amazon’s Q2’26 AWS Sales Grow At Fastest Pace In Five Years Stocktwits
Phathom Pharmaceuticals stock draws a Moderate Buy consensus - AD HOC NEWS
Phathom Pharmaceuticals stock draws a Moderate Buy consensus AD HOC NEWS
Phathom starts Phase 3 trial: Phathom Pharmaceuticals stock faces 2028 results - AD HOC NEWS
Phathom starts Phase 3 trial: Phathom Pharmaceuticals stock faces 2028 results AD HOC NEWS
Phathom Pharmaceuticals stock starts a new Phase 3 trial - AD HOC NEWS
Phathom Pharmaceuticals stock starts a new Phase 3 trial AD HOC NEWS
Phathom starts Phase 3 study: what it means for Phathom Pharmaceuticals stock - AD HOC NEWS
Phathom starts Phase 3 study: what it means for Phathom Pharmaceuticals stock AD HOC NEWS
Phathom’s Vonoprazan Trial Targets Episodic Heartburn Upside for PHAT Investors - TipRanks
Phathom’s Vonoprazan Trial Targets Episodic Heartburn Upside for PHAT Investors TipRanks